Navigation Links
Axiom Worldwide Convicted of Infringing a Hako-Med Patent
Date:9/18/2009

A federal jury in Tampa Florida returned a verdict in favor of Hako-Med finding that Axiom Worldwide willfully infringed Hako-Med's Horizontal Therapy patent and awarded damages(United States District Court, Middle District of Florida Case No.: 8:06-cv1790-T33AEP). In addition, the federal court issued another permanent injunction against Axiom Worldwide barring all EPS 8000 devices manufactured prior to November 28th 2006.

Honolulu, HI (PRWEB) September 18, 2009 -- A federal jury in Tampa Florida returned a verdict in favor of Hako-Med finding that Axiom Worldwide willfully infringed Hako-Med's Horizontal Therapy patent and awarded damages (United States District Court, Middle District of Florida Case No.: 8:06-cv1790-T33AEP). In addition, the federal court issued another permanent injunction against Axiom Worldwide barring all EPS 8000 devices manufactured prior to November 28th 2006.

A day earlier a federal judge in the United States District Court, Middle District of Florida, Tampa division, the honorable Virginia M. Hernandez Covington, made a temporary injunction against Axiom Worldwide permanent thereby baring Axiom Worldwide from using one of Hako-Med's trademarks.

Axiom Worldwide, based in Tampa Florida, manufactures spinal decompression devices as well as a pain management device, which was found to infringe on Hako-Med's unique patented pain therapy. Axiom Worldwide's head-engineer further admitted under oath that Axiom had done no validation through published clinical studies on their EPS 8000 devices prior to marketing the unsubstantiated claims to physicians that the EPS8000 devices "presents a breakthrough in electrical stimulation therapy" and "the most advanced Electrical Nerve stimulation available today."

Axiom Worldwide has additional pending litigation with other companies, including an alleged trademark infringement suit. (North American Medical vs. Axiom Worldwide No. 1:06-CV-1678-JTC)

Hako-Med offers a special amnesty period from civil litigations for any physician who wants to upgrade from an infringing device to Hako-Med Horizontal Therapy devices by the end of October 2009. (www.hakomed.com)

Hako-Med's policy is to vigorously defend its intellectual property portfolio. Hako-Med is the only manufacturer and supplier of devices with the patented Horizontal Therapy. Horizontal Therapy has been known through many clinical trials to outperform existing treatment methods in the treatment of pain from Osteoarthritis by having immediate as well as longer lasting therapeutic effects without any negative side effects.

For interviews please contact. Kai Hansjurgens president of Hako-Med USA at 1-888-913-7900 www.hakomed.com.

###

Read the full story at http://www.prweb.com/releases/Horizontal_Therapy/Patent_Infringement/prweb2905684.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. AXIOM Selects Foresight Corp. for Integration Partnership
2. Axiom Named to Healthcare Informatics Top 100 List
3. Axiom Consulting Partners Announces the Results of its Return On Sales Investment Survey
4. Global Decompression Announces C.O.D. Available on All Used Axiom DRX 9000 Spinal Decompression Systems
5. WorldatWork Publishes Axiom Consulting Partners' Article on ‘Planning for the New Normal', an Alternative Approach to Compensation Planning
6. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
7. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
8. Global Med Technologies(R) Extends Its Worldwide Outreach
9. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
10. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
11. New USAID grant helps Georgetown meet unmet family planning needs worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Axiom Worldwide Convicted of Infringing a Hako-Med Patent
(Date:7/24/2017)... PARK (PRWEB) , ... July 24, 2017 , ... Engineers ... is bio-compatible, because it produces the same kind of electrical energy that the body ... the form of moving electrons. This flow of electrons out of the battery is ...
(Date:7/24/2017)... ... , ... Cheerag D. Upadhyaya , M.D., M.Sc., FAANS has been appointed ... part of Saint Luke’s Health System . Dr. Upadhyaya has served in the ... FAANS joins Stanley P. Fisher, M.D., who has served as medical co-director ...
(Date:7/24/2017)... , ... July 24, 2017 , ... Cosmetic Town, an ... and the cosmetic surgeries they perform on a daily basis. , The new ... surgery procedures they specialize in at their practices. , When asked about the ...
(Date:7/24/2017)... ... 2017 , ... Horizon Goodwill Industries, SourceAmerica and ... high school girls succeed in STEM programs as well as help Horizon Goodwill ... over 20 high school girls at their corporate headquarters on Tuesday, July 25, ...
(Date:7/24/2017)... ... July 24, 2017 , ... Peruvian ... awards to be awarded annually to and divided between two full-time university students ... awareness to Amazonian plant medicine. To apply for the scholarship, students are asked ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)...  Eli Lilly and Company (NYSE: LLY ) ... resolve pending patent litigation in the U.S. District Court for ... the Cialis ® (tadalafil) unit dose patent. This patent ... part of the agreement, Cialis exclusivity is now expected to ... "The unit dose patent for Cialis is valid and infringed ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
Breaking Medicine Technology: